Tetrahydrobiopterin Availability in Parkinson’s and Alzheimer’s Disease; Potential Pathogenic Mechanisms

Author： Foxton Richard   Land John   Heales Simon  

Publisher： Springer Publishing Company

ISSN： 0364-3190

Source： Neurochemical Research, Vol.32, Iss.4-5, 2007-04, pp. : 751-756

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natural Antioxidants Protect Neurons in Alzheimer’s Disease and Parkinson’s Disease

By Zhao Baolu  

Neurochemical Research, Vol. 34, Iss. 4, 2009-04 ,pp. : 630-638

Springer Publishing Company

Access to resources Recommend Favorite

Interaction between Aβ Peptide and α Synuclein: Molecular Mechanisms in Overlapping Pathology of Alzheimer’s and Parkinson’s in Dementia with Lewy Body Disease

By Mandal Pravat   Pettegrew Jay   Masliah Eliezer   Hamilton Ronald   Mandal Ratna  

Neurochemical Research, Vol. 31, Iss. 9, 2006-09 ,pp. : 1153-1162

Springer Publishing Company

Access to resources Recommend Favorite

Cerebral atrophy in Parkinson’s disease with and without dementia: a comparison with Alzheimer’s disease, dementia with Lewy bodies and controls

By Burton Emma J.  

Brain, Vol. 127, Iss. 4, 2004-04 ,pp. : 791-800

Oxford University Press

Access to resources Recommend Favorite

Melatonin in Parkinson's disease

By Medeiros C.  

Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. : 759-759

Springer Publishing Company

Access to resources Recommend Favorite

A vaccine for Parkinson’s disease?

By Chesselet Marie-Francoise  

Future Neurology, Vol. 1, Iss. 1, 2006-01 ,pp. : 21-23

Future Medicine

Access to resources Recommend Favorite